EPHB4 and neoplasm: For Cycle Flux Intensity, EPHB4 and ERFE emerge as shared predictors across models; EPHB4 (EPH receptor B4) orchestrates vascular development and tissue remodelling; in oncologic contexts, it frequently connects to angiogenesis and microenvironment-driven tumor progression [37,38].